Cargando…
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
BACKGROUND AND AIMS: Surrogate endpoints that predict complications are necessary for assessment and approval of NASH therapies. We assessed associations between histologic and noninvasive tests (NITs) of fibrosis with liver‐related complications in patients with NASH cirrhosis. APPROACH AND RESULTS...
Autores principales: | Sanyal, Arun J., Anstee, Quentin M., Trauner, Michael, Lawitz, Eric J., Abdelmalek, Manal F., Ding, Dora, Han, Ling, Jia, Catherine, Huss, Ryan S., Chung, Chuhan, Wong, Vincent Wai‐Sun, Okanoue, Takeshi, Romero‐Gomez, Manuel, Muir, Andrew J., Afdhal, Nezam H., Bosch, Jaime, Goodman, Zachary, Harrison, Stephen A., Younossi, Zobair M., Myers, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303958/ https://www.ncbi.nlm.nih.gov/pubmed/34662449 http://dx.doi.org/10.1002/hep.32204 |
Ejemplares similares
-
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient‐Reported Outcomes
por: Younossi, Zobair M, et al.
Publicado: (2020) -
Nonalcoholic steatohepatitis: global impact and clinical consequences
por: Kabarra, Khaled, et al.
Publicado: (2021) -
Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016
por: Golabi, Pegah, et al.
Publicado: (2018) -
Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis
por: Sayiner, Mehmet, et al.
Publicado: (2018) -
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
por: Loomba, Rohit, et al.
Publicado: (2017)